At a glance
ClinicalIndex Comparison RecordN/ACompleted· 40 enrolled
Drug / intervention
Ivabradine +2 moredrug
Likely dose
Ivabradine 7.5mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
The Influence of Iatrogenic Chronotropic Incompetence on Exercise Tolerance in Pacemaker Patients With Chronic Heart Failure.
In Brief
A clinical study evaluating Ivabradine, Atrial fibrillation, and 1 other intervention for Chronic Heart Failure and 2 related conditions. Completed, enrolled 40 participants across 1 site.
Detailed Summary
To examine the effects of heart rate reduction on exercise capacity in control subjects and patients with chronic heart failure.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited Kingdom
Collaborators--
Timeline
N/ACompletedFinished
201520162017201820192020202120222023202420252026
Enrollment StartSep 2014
First PostedSep 2014
Primary CompletionSep 2015
TodayJul 2026
First PostedSep 23, 2014
Enrollment StartSep 1, 2014
Primary CompletionSep 1, 2015
TodayJul 2, 2026
Enrollment to primary: 1 yearPosted 11.8 years ago
Interventions
Ivabradinedrug
Ivabradine 7.5mg
Atrial fibrillationother
Pacemaker base rate alteration
Placebodrug
Placebo